Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and…
FDA rejects drug for rare blood disorder
 The US Food and Drug Administration has rejected a small molecule for a rare blood disorder called…